Condition
Umbilical Cord Blood Transplant
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 2 (1)
Trial Status
Withdrawn2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07381738Phase 2Recruiting
Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders
NCT03600896Phase 1WithdrawnPrimary
Recombinant Human Interleukin-7 (CYT107) to Promote T-Cell Recovery After Cord Blood Transplantation
NCT01247688Not ApplicableWithdrawn
Umbilical Cord Blood Transplant for Children With Lymphoid Hematological Malignancies
Showing all 3 trials